![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/10 | (2006.01) |
A61K 47/14 | (2013.01) | ||
A61K 47/14 | (2017.01) | ||
A61K 9/0095 | (2013.01) | ||
A61K 31/5377 | (2006.01) | ||
A61K 9/10 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 31/5377 | (2013.01) | ||
A61P 35/00 | (2018.01) |
(11) | Number of the document | 2958550 |
(13) | Kind of document | T |
(96) | European patent application number | 14710642.1 |
Date of filing the European patent application | 2014-02-21 | |
(97) | Date of publication of the European application | 2015-12-30 |
(45) | Date of publication and mention of the grant of the patent | 2022-08-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2014/059161 |
Date | 2014-02-21 |
(87) | Number | WO 2014/128661 |
Date | 2014-08-28 |
(30) | Number | Date | Country code |
201361768803 P | 2013-02-25 | US |
(72) |
DECAUDIN, Céline , CH
ROGUE, Vincent , CH
|
(73) |
Sun Pharmaceutical Industries Limited ,
SPARC, TANDALJA, Vadodara, Gujarat-390012,
IN
|
(54) | ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG |
ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG |